Patents by Inventor Amy S. Paller

Amy S. Paller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11633503
    Abstract: The present invention relates to compositions and methods for delivering an oligonucleotide-functionalized nanoparticle.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: April 25, 2023
    Assignee: Northwestern University
    Inventors: Chad A. Mirkin, Amy S. Paller, David A. Giljohann
  • Publication number: 20190030185
    Abstract: The present invention relates to compositions and methods for delivering an oligonucleotide-functionalized nanoparticle.
    Type: Application
    Filed: October 15, 2018
    Publication date: January 31, 2019
    Inventors: Chad A. Mirkin, Amy S. Paller, David A. Giljohann
  • Patent number: 10098958
    Abstract: The present invention relates to compositions and methods for delivering an oligonucleotide-functionalized nanoparticle.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: October 16, 2018
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Chad A. Mirkin, Amy S. Paller, David A. Giljohann
  • Publication number: 20170290944
    Abstract: The present invention provides compositions and methods that promote wound healing in a subject with a cutaneous injury. In particular, the present invention provides systemic and/or local administration of one or more compositions that cause ganglioside depletion (e.g., glucosylceramide synthase (GCS) inhibitors) for the treatment of cutaneous wounds.
    Type: Application
    Filed: April 24, 2017
    Publication date: October 12, 2017
    Inventor: Amy S. Paller
  • Publication number: 20160095929
    Abstract: The present invention provides compositions and methods that promote wound healing in a subject with a cutaneous injury. In particular, the present invention provides systemic and/or local administration of one or more compositions that cause ganglioside depletion (e.g., glucosylceramide synthase (GCS) inhibitors) for the treatment of cutaneous wounds.
    Type: Application
    Filed: April 29, 2015
    Publication date: April 7, 2016
    Inventor: Amy S. Paller
  • Publication number: 20130040953
    Abstract: The present invention provides compositions and methods that promote wound healing in a subject with a cutaneous injury. In particular, the present invention provides systemic and/or local administration of one or more compositions that cause ganglioside depletion (e.g., glucosylceramide synthase (GCS) inhibitors) for the treatment of cutaneous wounds.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 14, 2013
    Inventor: Amy S. Paller
  • Publication number: 20100233270
    Abstract: The present invention relates to compositions and methods for delivering an oligonucleotide-functionalized nanoparticle.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 16, 2010
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Chad A. Mirkin, Amy S. Paller, David A. Giljohann
  • Publication number: 20020122795
    Abstract: The invention is a pharmacological composition that contains at least one ganglioside or portion thereof. The composition can be used to treat skin disorders.
    Type: Application
    Filed: December 7, 2001
    Publication date: September 5, 2002
    Inventor: Amy S. Paller